The scar removal treatment market size was valued at USD 25.1 Billion in 2022. The scar removal treatment industry is projected to grow from USD 27.38 Billion in 2023 to USD 54.96 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.10% during the forecast period (2023 - 2032). The growing concern among people related to their aesthetic appearance, rising disposable income, rising personal care expenditure, and rising number of accidents, including burns and road accidents, are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for scar removal treatment is driven by the technological advancements in scar treatment, and growing consumer appearance consciousness are significant factors driving the  scar treatment market. In addition, the growing prevalence of plastic surgery, increasing incidences of road accidents leading to the most common injuries, and the rise in awareness over the availability of treatment procedures further promote the growth rate of the  scar removal treatment market. Nearly 20-30 million people are prone to road accident injuries. These people may develop scars that cannot be reduced, and some can be reduced. People with scars can be treatable under scar treatment which drives the market forward. Most of these people use laser treatment to reduce these scars.
Additionally, the increasing number of road accidents is expected to propel the growth of the scar treatment market going forward. Road accidents refer to an incident involving at least one vehicle on a public road that results in at least one person being hurt or killed. Accidental burns, abrasions, scrapes, or cuts to the skin result in a natural healing and tissue replacement process that frequently leaves scars behind. The appearance of these scars can be significantly reduced with unique scar treatments that treat the damaged layers of skin and produce noticeable effects. For instance, in June 2022, as per the report shared by the RAC Foundation, a UK-based registered charity and transport policy organization, a recorded traffic collision resulted in an anticipated 1,558 fatalities in 2021, a 7% increase from 2020. The expected number of killed or seriously injured (KSI) casualties was 27,450, a 14% rise from 2020. Therefore, the increasing number of road accidents is driving the scar removal treatment market revenue.
The growing incidences of skin diseases are one of the significant driving factors that accelerate market growth around the world. Several major skin diseases, such as photoaging, psoriasis, vitiligo, and eczema, occur among the population because of extreme exposure to ultraviolet (UV) radiation and pollution. As a result, these factors may lead to reduced skin elasticity, hair loss, sunburns, etc. Consequently, these conditions that have not received suitable treatment on time can lead to the formation of marks. Numerous additional skin-related problems, such as post-surgical marks, acne, stretch marks due to pregnancy or changes in body weight, and burn marks, also lead to the development of marks. A large population is affected by acne, a most common dermatological condition that eventually leads to the formation of marks.
The mounting occurrence of skin diseases such as vitiligo, psoriasis, eczema, and photoaging of the skin, technological advancement in products, escalating appearance consciousness among consumers, mounting number of surgical procedures, and intensifying disposable income are the key factors leading to the growth of the market, ly. For instance, as per the American Academy of Dermatology, in the U.S., annually, approximately 50 million Americans suffer from acne.
The scar removal treatment market segmentation, based on treatment type, includes surgical, laser, topical, and injectable. The laser segment dominated the market, accounting for 35% of market revenue (9.58 Billion). In developing economies, category growth is driven as Laser scar treatment is the latest and most advanced technology for scar treatment. However, topical is the fastest-growing category owing to the easy availability of topical products and the rise in consciousness regarding aesthetic appearance.
The scar removal treatment market segmentation, based on application, includes keloid scars, contracture scars, hypertrophic scars, acne scars, and others. The keloid scars category generated the most income (70.4%) due to the prevalence among the population with wound injuries. However, acne scars are the fastest-growing category due to the skin's insufficiency to produce adequate collagen to heal the scar or injury. These types of scars are generally treated with lotions, oils, gels, and creams that are easily available as OTC products.
The scar removal treatment market segmentation, based on end-user, includes hospitals and dermatology clinics. The hospitals category generated the most income owing to the utilization of sophisticated infrastructure and the existence of technologically progressive products in these settings for scar treatment. However, acne scars are the fastest-growing category due to high scars incidences.
Figure 1 Scar Removal Treatment Market by End-User, 2022 & 2032 (USD Billion)
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
By region, the study delivers market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American scar removal treatment market will dominate, owing to the high aesthetic consciousness among people, and the rising adoption of enhanced products will boost the market growth in this region. Further, the German scar removal treatment market held the largest market share, and the UK scar removal treatment market was the fastest-growing market in the North American region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2 SCAR REMOVAL TREATMENT MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's scar removal treatment market accounts for the second-largest market share owing to an increased desire among the population to look beautiful and high per capita expenditure on cosmetic procedures. Further, the German scar removal treatment market held the largest market share, and the UK scar removal treatment market was the fastest-growing market in the European region.
The Asia-Pacific scar removal treatment market is expected to grow at the fastest CAGR from 2023 to 2032 as many players in the region are focusing on R&D to introduce new products, and technological advancements in treatment products drive the market in this region. Moreover, China’s scar removal treatment market held the largest market share, and the Indian scar removal treatment market was the fastest-growing market in the Asia-Pacific region.
Scar Removal Treatment Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the scar removal treatment market grow even more. Market participants are also undertaking multiple strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the scar removal treatment industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the scar removal treatment industry to benefit clients and increase the market sector. Major players in the scar removal treatment market, including Asclepion Laser Technologies GmbH, Absolute MS (S) Pte Ltd., Avita Medical, Biodermis, Cynosure Inc., Enaltus LLC., and others, are attempting to increase market demand by investing in research and development operations.
Sanofi is a healthcare company engaged in discovering, developing, manufacturing, and marketing a broad variety of medicines and vaccines. Its portfolio includes medicines for treating cancer, rare diseases, and multiple sclerosis, human vaccines for protection against numerous bacterial and viral diseases; and other products. The company also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women's health; and vitamins, minerals, and supplements. Sanofi's R&D efforts focus on enhancing a combination drug to enhance the effectiveness of treatments and on advancing the formulation of new biologics to produce precision medicines. In December 2021, Sanofi S.A. acquired Origimm Biotechnology GmbH for an undisclosed amount. Through this acquisition, Sanofi has expanded its vaccine R&D pipeline, knowledge of the skin microbiome and skin immunology, and acne disease therapy possibilities to the rest of Europe. Origimm Biotechnology GmbH is an Austria-based provider of effective treatments for acne to avoid any potential skin damage or scarring.
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is engaged in the manufacturing, developing, and marketing of a range of medical devices, over-the-counter products (OTC), and pharmaceutical products. Bausch Health offers products for therapy areas related to dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It offers various generic and branded generic products. Bausch Health has administrative, research and laboratory, marketing, distribution, and warehousing facilities worldwide. The company offers products directly or indirectly in various regions across the world. In June 2020, Bausch Health Companies Inc. launched an ARAZLOT (tazarotene) Lotion, approved by U.S. Food and Drug Administration. It is the first tazarotene acne treatment available in a lotion formulation.
Key Companies in the Scar Removal Treatment market include
Scar Removal Treatment Industry Developments
September 2021Â SkinCeuticals, a Medical Skincare Brand, introduced its latest innovation, Advanced Scar Control. The new semi-occlusive treatment is designed to protect vulnerable skin to support and improve the appearance of unique and recent scars.
In July 2019, Dermatix Acne Scar Cream was launched by Dermatix, a brand under Menarini Singapore Pte. Ltd. The Dermatix Acne Scar Cream helps repair acne scars through exfoliation. In addition, it comprises vitamin B3, antioxidants, and alpha-hydroxy acids (AHAs). It is beneficial for acne aftereffects, which include scars and dark spots.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 25.1 Billion |
| Market Size 2023 | USD 27.38 Billion |
| Market Size 2032 | USD 54.96 Billion |
| Compound Annual Growth Rate (CAGR) | 9.10% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Treatment Type, Application, End-User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Asclepion Laser Technologies GmbH, Absolute MS (S) Pte Ltd., Avita Medical, Biodermis, Enaltus LLC., Merz Pharma, Revitol.com, Cynosure Inc., Scarguard Labs LLC, Suneva Medical, Inc., TorquePharma, WONTECH, and Z-Roc Dermatology |
| Key Market Opportunities | Rising number of accidents, including burns and road accidents |
| Key Market Dynamics | The rising concern among people related to their aesthetic appearance |
Frequently Asked Questions (FAQ) :
The scar removal treatment market size was valued at USD 25.1 Billion in 2022.
The market is projected to grow at a CAGR of 9.10% during the forecast period, 2023-2032.
North America had the largest share of the market
The key players in the market are Biodermis, Cynosure Inc., Avita Medical, Enaltus LLC., Merz Pharma, Scarguard Labs LLC, Revitol.com, Suneva Medical, Inc., TorquePharma, WONTECH, and Z-Roc Dermatology.
The laser category dominated the market in 2022.
The keloid scars had the largest share in the market.
The hospitals had the largest share of the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
